PreveCeutical Medical Inc. (PREV.CN) Research

PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.

Market snapshot

Symbol
PREV.CN
Price
$0.03
Day change
+25.00%
Market cap
$15.0M
P/E ratio
-9.21x
52-week range
0.015-0.06
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Britannia Life Sciences Inc. (BLAB.CN)
  • Rapid Dose Therapeutics Corp. (DOSE.CN)
  • Hemostemix Inc. (HEM.V)
  • Pharmala Biotech Holdings Inc. (MDMA.CN)
  • Pangenomic Health Inc. (NARA.CN)
  • PharmaTher Holdings Ltd. (PHRM.CN)
  • Red White & Bloom Brands Inc. (RWB.CN)
  • Telescope Innovations Corp. (TELI.CN)

Open PreveCeutical Medical Inc. (PREV.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.